EXAGEN INC.

XGN · Nasdaq · SIC 8071: Services-Medical Laboratories
125
SEC Filings

Business Summary

Business 79 Section 9.05.Investments 79 Section 9.06.Restricted Payments 80 Section 9.07.Payments of Indebtedness 81 Section 9.08.Change in Fiscal Year 81 Section 9.09.Sales of Assets, Etc 81 Section 9.10.Transactions with Affiliates 82 Section 9.11.Restrictive Agreements 83 Section 9.12.Organizational Documents, Material Agreements 83 Section 9.13.Anti-Terrorism and Anti-Corruption Laws 83 Section 9.14.Sales and Leasebacks 83 Section 9.15.Hazardous Material 83 Section 9.16.Accounting Changes 84...

Next Earnings

Q2 FY2026 — expected 2026-07-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionXGNdiscussed_in_filing Blockchain & Crypto
topic_mentionXGNdiscussed_in_filing Regulation
topic_mentionXGNdiscussed_in_filing Healthcare & Bio
topic_mentionXGNdiscussed_in_filing Sovereign & Government
topic_mentionXGNdiscussed_in_filing Blockchain & Crypto
topic_mentionXGNdiscussed_in_filing Regulation
topic_mentionXGNdiscussed_in_filing Healthcare & Bio
topic_mentionXGNdiscussed_in_filing Sovereign & Government
topic_mentionXGNdiscussed_in_filing Blockchain & Crypto
topic_mentionXGNdiscussed_in_filing Regulation
topic_mentionXGNdiscussed_in_filing Healthcare & Bio
topic_mentionXGNdiscussed_in_filing Sovereign & Government
topic_mentionXGNdiscussed_in_filing Blockchain & Crypto
topic_mentionXGNdiscussed_in_filing Regulation
topic_mentionXGNdiscussed_in_filing Healthcare & Bio
topic_mentionXGNdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001274737-26-000009EDGAR79K words
2025-03-112024-12-310001274737-25-000019EDGAR—
2024-03-182023-12-310001274737-24-000022EDGAR—
2023-03-202022-12-310001274737-23-000019EDGAR—
2022-03-222021-12-310001628280-22-006926EDGAR—
2021-03-162020-12-310001274737-21-000015EDGAR—
2020-03-252019-12-310001274737-20-000026EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001274737-25-000071EDGAR22K words
2025-07-292025-06-300001274737-25-000063EDGAR—
2025-05-052025-03-310001274737-25-000026EDGAR—
2024-11-122024-09-300001274737-24-000092EDGAR—
2024-08-052024-06-300001274737-24-000079EDGAR—
2024-05-132024-03-310001274737-24-000048EDGAR—
2023-11-132023-09-300001274737-23-000103EDGAR—
2023-08-072023-06-300001274737-23-000088EDGAR—
2023-05-152023-03-310001274737-23-000049EDGAR—
2022-11-212022-09-300001274737-22-000076EDGAR—
2022-08-042022-06-300001274737-22-000052EDGAR—
2022-05-112022-03-310001274737-22-000028EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001274737-26-000007EDGAR3K words
2026-01-120001274737-26-000003EDGAR—
2025-11-040001274737-25-000069EDGAR—
2025-07-290001274737-25-000061EDGAR—
2025-07-170001274737-25-000055EDGAR—
2025-06-110001274737-25-000036EDGAR—
2025-05-090001193125-25-116881EDGAR—
2025-05-080001193125-25-115946EDGAR—
2025-05-050001274737-25-000023EDGAR—
2025-04-280001193125-25-100447EDGAR—

125 total filings indexed. 96 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

AMS — AMERICAN SHARED HOSPITAL SERVICES ACON — Aclarion, Inc. ADVB — Advanced Biomed Inc. BDSX — BIODESIX INC BLLN — BillionToOne, Inc. BGLC — BioNexus Gene Lab Corp CSTL — CASTLE BIOSCIENCES INC CFOR — CapForce Inc.

Company Identity

CIK0001274737
TickerXGN
ExchangeNasdaq
SIC8071: Services-Medical Laboratories
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c71b1ba039931666976714fdf2019aa4ca24fe990e8da500e2bd13e11d482ea3
parent: 9e100142390c713ef32a065d7644f01334fd30506acf6a819255384f2e0e5031
content hash: 8ec9ff5ad956158bab34fe107ddbb539980de648c209d70a6256f046ab9dbcfa
signed: 2026-04-13T04:48:17.966Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf